Market Cap | ₹16Cr |
ROE | 8.32% |
P/E Ratio(TTM) | -13.42 |
EPS(TTM) | -1.18 |
P/B Ratio | 0.00 |
Dividend Yield | 0.00% |
Industry P/E | 40.33 |
Book Value | -14.79 |
Debt to Equity | -1.45 |
Face Value | 10 |
Parent Organisation | Norris Medicines Limited |
BSE Symbol | 524414 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 105.21 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
Wockhardt | NA (0.00%) | -154.77 |